News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
631,226 Results
Type
Article (50184)
Company Profile (243)
Press Release (580799)
Section
Business (180179)
Career Advice (1206)
Deals (31123)
Drug Delivery (97)
Drug Development (73609)
Employer Resources (106)
FDA (15771)
Job Trends (14193)
News (307349)
Policy (30586)
Tag
Academia (2630)
Alliances (44032)
Alzheimer's disease (1219)
Approvals (15730)
Artificial intelligence (149)
Bankruptcy (264)
Best Places to Work (11431)
Biotechnology (178)
Breast cancer (190)
Cancer (1359)
Cardiovascular disease (109)
Career advice (1038)
Cell therapy (279)
Clinical research (58958)
Collaboration (470)
Compensation (231)
COVID-19 (2523)
C-suite (121)
Data (1389)
Diabetes (169)
Diagnostics (5798)
Earnings (67540)
Employer resources (96)
Events (104311)
Executive appointments (409)
FDA (16456)
Funding (400)
Gene therapy (193)
GLP-1 (600)
Government (4565)
Healthcare (19231)
Infectious disease (2613)
Inflammatory bowel disease (117)
Interviews (171)
IPO (14385)
Job creations (3240)
Job search strategy (946)
Layoffs (381)
Legal (6577)
Lung cancer (204)
Lymphoma (98)
Manufacturing (198)
Medical device (13854)
Medtech (13858)
Mergers & acquisitions (16936)
Metabolic disorders (446)
Neuroscience (1515)
NextGen Class of 2024 (6438)
Non-profit (4523)
Northern California (1663)
Obesity (258)
Opinion (166)
Patents (98)
People (56184)
Phase I (18151)
Phase II (25869)
Phase III (19826)
Pipeline (492)
Postmarket research (2403)
Preclinical (7387)
Radiopharmaceuticals (252)
Rare diseases (256)
Real estate (5160)
Regulatory (20899)
Research institute (2406)
Resumes & cover letters (147)
Southern California (1393)
Startups (3398)
United States (14745)
Vaccines (574)
Weight loss (183)
Date
Today (33)
Last 7 days (596)
Last 30 days (2392)
Last 365 days (34393)
2024 (34200)
2023 (39200)
2022 (50073)
2021 (54238)
2020 (52382)
2019 (45924)
2018 (34861)
2017 (31166)
2016 (30285)
2015 (35423)
2014 (27072)
2013 (22443)
2012 (23953)
2011 (24532)
2010 (23312)
Location
Africa (719)
Arizona (143)
Asia (40294)
Australia (6422)
California (3670)
Canada (1328)
China (316)
Colorado (179)
Connecticut (183)
Europe (83131)
Florida (518)
Georgia (132)
Illinois (420)
Indiana (226)
Maryland (636)
Massachusetts (2901)
Michigan (129)
Minnesota (276)
New Jersey (1081)
New York (1028)
North Carolina (813)
Northern California (1663)
Ohio (135)
Pennsylvania (876)
South America (988)
Southern California (1393)
Texas (521)
Utah (111)
Washington State (392)
631,226 Results for "hutchison china meditech chi med".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
One year after a potential $1.7 billion deal with Hansoh Pharma, GSK goes back to China to forge another alliance with DualityBio for another deal that could be worth up to $1 billion as it continues to build up its ADC portfolio.
December 4, 2024
·
1 min read
·
Kate Goodwin
Podcast
AbbVie’s Surprise Schizophrenia Flop, AstraZeneca’s China Drama, Hope in Huntington’s, More
A tale of two multi-billion schizophrenia deals, AstraZeneca touts strong sales while deflecting questions about an investigation into China exec, the Huntington’s pipeline builds momentum and layoffs continue with Sana Biotechnology and 23andMe.
November 13, 2024
·
1 min read
·
Heather McKenzie
Drug Development
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
On June 25, China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) announced the completion of dosing for the first subject in the phase III bridging trial of ruxolitinib cream (the “Product”) in atopic dermatitis (“AD”) in China.
June 25, 2024
·
8 min read
Policy
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System Holdings Limited is pleased to announce that on 11 June 2024, the New Drug Application of the Group’s innovative drug methylthioninium chloride enteric-coated sustained-release tablets has been approved by the National Medical Products Administration of China.
June 18, 2024
·
7 min read
MEDITECH to Spotlight Intelligent Interoperability at HIMSS24
MEDITECH is once again excited to feature its latest interoperability innovations in the HIMSS Interoperability Showcase.
March 7, 2024
·
5 min read
Press Releases
Inari Medical Announces Joint Venture in Greater China
December 3, 2024
·
4 min read
Weight loss
Novo’s Wegovy Launched in China at a Fraction of US Price
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine for about $193.27 for a one-month supply.
November 18, 2024
·
1 min read
·
Annalee Armstrong
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that on 22 April 2024, the New Drug Application (NDA) of Desidustat Tablets (“Desidustat Tablets” or the “Product”) has been accepted by the National Medical Products Administration of China (NMPA).
April 23, 2024
·
4 min read
Press Releases
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China’s National Medical Products Administration
December 20, 2024
·
7 min read
Press Releases
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
December 10, 2024
·
4 min read
1 of 63,123
Next
